Trial Profile
Exemestane versus anastrozole in postmenopausal women with hormone positive early breast cancer (EBC)
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2014
Price :
$35
*
At a glance
- Drugs Exemestane (Primary) ; Anastrozole
- Indications Early breast cancer
- Focus Therapeutic Use
- 15 Apr 2014 New trial record
- 21 Mar 2014 Results after 3 years presented at the 9th European Breast Cancer Conference.